| | | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
|---|
|
|
| | | FI | PI | CM | Fluvastatin Sandoz Retard | 28 Tablette(n) | 14.71 | 29.20 | 10% | 1.04 | Retard-Tabletten: Fluvastatinum 80 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | | FI | PI | CM | Fluvastatin Sandoz Retard | 98 Tablette(n) | 51.40 | 75.40 | 10% | 0.77 | Retard-Tabletten: Fluvastatinum 80 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Risperidon Spirig HC 0.5 | 20 Tablette(n) | 4.94 | 9.75 | 10% | 4.88 | Filmtabletten: Risperidonum | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Risperidon Spirig HC 1 | 20 Tablette(n) | 8.92 | 18.45 | 10% | 4.61 | Filmtabletten: Risperidonum 1 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Risperidon Spirig HC 1 | 60 Tablette(n) | 22.73 | 42.50 | 10% | 3.54 | Filmtabletten: Risperidonum 1 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Risperidon Spirig HC 2 | 20 Tablette(n) | 14.75 | 29.25 | 10% | 3.66 | Filmtabletten: Risperidonum 2 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Risperidon Spirig HC 2 | 60 Tablette(n) | 37.60 | 59.55 | 10% | 2.48 | Filmtabletten: Risperidonum 2 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Risperidon Spirig HC 3 | 20 Tablette(n) | 21.91 | 41.55 | 10% | 3.46 | Filmtabletten: Risperidonum 3 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Risperidon Spirig HC 3 | 60 Tablette(n) | 55.68 | 80.30 | 10% | 2.23 | Filmtabletten: Risperidonum 3 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Risperidon Spirig HC 4 | 20 Tablette(n) | 28.35 | 48.95 | 10% | 3.06 | Filmtabletten: Risperidonum 4 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Risperidon Spirig HC 4 | 60 Tablette(n) | 72.30 | 99.40 | 10% | 2.07 | Filmtabletten: Risperidonum 4 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Risperidon Spirig HC 6 | 20 Tablette(n) | 35.93 | 57.65 | 10% | 2.88 | Filmtabletten: Risperidonum 6 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Risperidon Spirig HC 6 | 60 Tablette(n) | 91.31 | 121.20 | 10% | 2.02 | Filmtabletten: Risperidonum 6 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Co-Perindopril Spirig HC | 30 Tablette(n) | 15.59 | 34.30 | 10% | | Tabletten: 2 Wirkstoffe | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Co-Perindopril Spirig HC | 90 Tablette(n) | 39.75 | 62.05 | 10% | | Tabletten: 2 Wirkstoffe | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | FI | PI | | Azarga | 5 ml | 18.71 | 37.90 | 10% | | Augentropfen: 2 Wirkstoffe | Novartis Pharma
Schweiz AG | B / SL | FB | | G | |
| | | FI | PI | | Azarga | 3 x 5 ml | 53.34 | 77.65 | 10% | | Augentropfen: 2 Wirkstoffe | Novartis Pharma
Schweiz AG | B / SL | FB | | G | |
| | | FI | PI | BM | Methadon Streuli 10 mg/ml | Flasche(n) à 100 ml | 10.80 | 20.60 | 10% | 0.52 | Infusionslösung: Methadoni Hydrochloridum 10 mg/ml | Streuli Pharma AG | A / SL | FB | | G | |
| L | | FI | PI | | NovoSeven 1 mg | Set(s) | 845.41 | 907.55 | 10% | | raumtemperaturstabiles Injektionspräparat: Eptacogum Alfa 1 mg | Novo Nordisk Pharma AG | B / SL | FB | | G | |
| L | | FI | PI | | NovoSeven 2 mg | Set(s) | 1690.88 | 1774.15 | 10% | | raumtemperaturstabiles Injektionspräparat: Eptacogum Alfa 2 mg | Novo Nordisk Pharma AG | B / SL | FB | | G | |
| L | | FI | PI | | NovoSeven 5 mg | Set(s) | 4224.20 | 4370.80 | 10% | | raumtemperaturstabiles Injektionspräparat: Eptacogum Alfa 5 mg | Novo Nordisk Pharma AG | B / SL | FB | | G | |
| L | | FI | | CM | Helixate M2 V 250 I.E. | Set(s) | 258.54 | 306.00 | 10% | | Lyophilisat: Factor Viii Coagulationis Humanus 250 UI
Lyophilisat: Alcohol Isopropylicus | CSL Behring AG | B / SL | FB | | G | |
| L | | FI | | CM | Helixate M2 V 500 I.E. | Set(s) | 516.88 | 570.80 | 10% | | Lyophilisat: Factor Viii Coagulationis Humanus 500 UI
Lyophilisat: Alcohol Isopropylicus | CSL Behring AG | B / SL | FB | | G | |
| L | | FI | | CM | Helixate M2 V 1000 I.E. | Set(s) | 1033.80 | 1100.65 | 10% | | Lyophilisat: Factor Viii Coagulationis Humanus 1000 UI
Lyophilisat: Alcohol Isopropylicus | CSL Behring AG | B / SL | FB | | G | |
| L | | FI | | CM | Helixate M2 V 2000 I.E. | Set(s) | 2040.10 | 2132.10 | 10% | | Lyophilisat: Factor Viii Coagulationis Humanus 2000 UI
Lyophilisat: Alcohol Isopropylicus | CSL Behring AG | B / SL | FB | | G | |
| L | KFI | FI | | | Ribomustin 25 mg | Durchstechflasche(n) | 94.21 | 124.55 | 10% | | Lyophilisat für Infusionslösung: Bendamustini Hydrochloridum 25 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A / SL | FB | | G | |
| L | KFI | FI | | | Ribomustin 25 mg | 5 Durchstechflasche(n) | 391.51 | 465.85 | 10% | | Lyophilisat für Infusionslösung: Bendamustini Hydrochloridum 25 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A / SL | FB | | G | |
| L | KFI | FI | | | Ribomustin 100 mg | Durchstechflasche(n) | 304.95 | 366.50 | 10% | | Lyophilisat für Infusionslösung: Bendamustini Hydrochloridum 100 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A / SL | FB | | G | |
| L | KFI | FI | PI | PS | Arcoxia 30 mg ‐ F | 28 Tablette(n) | 20.26 | 39.65 | 10% | 2.83 | Filmtabletten: Etoricoxibum 30 mg | MSD Merck Sharp &
Dohme AG | B / SL | FB | | G | |
| L | KFI | FI | PI | PS | Arcoxia 60 mg | 7 Tablette(n) | 8.04 | 17.45 | 10% | 2.49 | Filmtabletten: Etoricoxibum 60 mg | MSD Merck Sharp &
Dohme AG | B / SL | FB | | G | |
| L | KFI | FI | PI | PS | Arcoxia 60 mg | 28 Tablette(n) | 32.16 | 53.30 | 10% | 1.90 | Filmtabletten: Etoricoxibum 60 mg | MSD Merck Sharp &
Dohme AG | B / SL | FB | | G | |
| | | FI | PI | Ph | Kaloba | 20 ml | 7.67 | 14.15 | 10% | | Lösung: Pelargonii Sidoides Radicis Extractum Ethanolicum Liquidum 800 mg/g | Schwabe Pharma AG | D / SL | FB | | G | |
| | | FI | PI | Ph | Kaloba | 50 ml | 14.67 | 27.05 | 10% | | Lösung: Pelargonii Sidoides Radicis Extractum Ethanolicum Liquidum 800 mg/g | Schwabe Pharma AG | D / SL | FB | | G | |
| | | FI | | | OLIMEL 5,7 % ohne
Elektrolyte | 6 x 1000 ml | PA | PA | k.A. | | | Baxter AG | B | FB | | G | |
| | | FI | | | OLIMEL 5,7 % ohne
Elektrolyte | 4 x 1500 ml | PA | PA | k.A. | | | Baxter AG | B | FB | | G | |
| | | FI | | | OLIMEL 5,7 % mit
Elektrolyte | 6 x 1000 ml | PA | PA | k.A. | | | Baxter AG | B | FB | | G | |
| | | FI | | | OLIMEL 5,7 % mit
Elektrolyte | 4 x 1500 ml | PA | PA | k.A. | | | Baxter AG | B | FB | | G | |
| | | FI | | | PeriOLIMEL 2,5 % mit
Elektrolyte | 4 x 1500 ml | PA | PA | k.A. | | | Baxter AG | B | FB | | G | |
| | | FI | PI | BM | Methadon Streuli 10 mg/ml | Flasche(n) à 500 ml | PA | PA | k.A. | | Infusionslösung: Methadoni Hydrochloridum 10 mg/ml | Streuli Pharma AG | A | FB | | G | |
| | | FI | PI | BM | Methadon Streuli 10 mg/ml | Flasche(n) à 1000 ml | PA | PA | k.A. | | Infusionslösung: Methadoni Hydrochloridum 10 mg/ml | Streuli Pharma AG | A | FB | | G | |
| | | | PI | H | Camilia | 10 x 1 ml | PA | PA | k.A. | | Lösung (oral): 3 Wirkstoffe | Boiron SA | D | FB | | G | |
| | | | PI | H | Camilia | 30 x 1 ml | PA | PA | k.A. | | Lösung (oral): 3 Wirkstoffe | Boiron SA | D | FB | | G | |
| | | FI | | | OLIMEL 3,3 % mit
Elektrolyte | 4 x 1500 ml | PA | PA | k.A. | | | Baxter AG | B | FB | | G | |
| | | FI | | | OLIMEL 4,4 % mit
Elektrolyte | 4 x 1500 ml | PA | PA | k.A. | | | Baxter AG | B | FB | | G | |
| | | FI | | | OLIMEL 5,7 % mit
Elektrolyte | 4 x 2000 ml | PA | PA | k.A. | | | Baxter AG | B | FB | | G | |
| | | FI | | | PeriOLIMEL 2,5 % mit
Elektrolyte | 4 x 2000 ml | PA | PA | k.A. | | | Baxter AG | B | FB | | G | |
| | | FI | PI | BM | Methadon Streuli 10 mg/ml | Flasche(n) à 50 ml | PA | PA | k.A. | | Infusionslösung: Methadoni Hydrochloridum 10 mg/ml | Streuli Pharma AG | A | FB | | G | |
| | | FI | PI | BM | Methadon Streuli 20 mg/ml | Flasche(n) à 50 ml | PA | PA | k.A. | | Infusionslösung: Methadoni Hydrochloridum 20 mg/ml | Streuli Pharma AG | A | FB | | G | |
| | | FI | PI | BM | Methadon Streuli 20 mg/ml | Flasche(n) à 100 ml | PA | PA | k.A. | | Infusionslösung: Methadoni Hydrochloridum 20 mg/ml | Streuli Pharma AG | A | FB | | G | |
| | | FI | PI | BM | Methadon Streuli 50 mg/ml | Flasche(n) à 50 ml | PA | PA | k.A. | | Infusionslösung: Methadoni Hydrochloridum 50 mg/ml | Streuli Pharma AG | A | FB | | G | |
| | | FI | PI | BM | Methadon Streuli 50 mg/ml | Flasche(n) à 100 ml | PA | PA | k.A. | | Infusionslösung: Methadoni Hydrochloridum 50 mg/ml | Streuli Pharma AG | A | FB | | G | |
| | | FI | | | OLIMEL 4,4 % ohne
Elektrolyte | 6 x 1000 ml | PA | PA | k.A. | | | Baxter AG | B | FB | | G | |
| | | FI | PI | | NovoSeven 8 mg | Set(s) | PA | PA | k.A. | | raumtemperaturstabiles Injektionspräparat: Eptacogum Alfa 8 mg | Novo Nordisk Pharma AG | B | FB | | G | |
| | | FI | | BMCM | Zürcher Bahnhof Apotheke
Bronchialpastillen mit
Codein | 24 Stück | PA | PA | k.A. | | Pastillen: Codeini Phosphas Hemihydricus 3 mg | Iromedica AG | C | FB | | G | |
| | KFI | FI | | | Ribomustin 25 mg | 10 Durchstechflasche(n) | PA | PA | k.A. | | Lyophilisat für Infusionslösung: Bendamustini Hydrochloridum 25 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A | FB | | G | |
| | KFI | FI | | | Ribomustin 25 mg | 20 Durchstechflasche(n) | PA | PA | k.A. | | Lyophilisat für Infusionslösung: Bendamustini Hydrochloridum 25 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A | FB | | G | |
| | KFI | FI | | | Ribomustin 100 mg | 5 Durchstechflasche(n) | PA | PA | k.A. | | Lyophilisat für Infusionslösung: Bendamustini Hydrochloridum 100 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A | FB | | G | |
| | | FI | PI | Ph | Kaloba | 100 ml | PA | PA | k.A. | | Lösung: Pelargonii Sidoides Radicis Extractum Ethanolicum Liquidum 800 mg/g | Schwabe Pharma AG | D | FB | | G | |
